(Q36982787)

17 August 2017

1 reference

title

Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects (English)

1 reference

17 August 2017

1 reference

1 reference

O S Tang

1

1 reference

17 August 2017

K Gemzell-Danielsson

series ordinal

2

1 reference

17 August 2017

P C Ho

series ordinal

3

1 reference

17 August 2017

publication date

26 October 2007

1 reference

International Journal of Gynecology and Obstetrics

17 August 2017

published in

1 reference

17 August 2017

volume

99 Suppl 2

1 reference

17 August 2017

page(s)

S160-7

1 reference

Pharmacokinetics of different routes of administration of misoprostol

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Oral, rectal, and vaginal pharmacokinetics of misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Misoprostol administered by epithelial routes: Drug absorption and uterine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Buccal versus intravaginal misoprostol administration for cervical ripening

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Comparison of misoprostol plasma concentrations following buccal and sublingual administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Misoprostol versus methylergometrine: pharmacokinetics in human milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Effects of misoprostol on uterine contractility following different routes of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

The effect of orally and vaginally administered misoprostol on inflammatory mediators and cervical ripening during early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Preclinical toxicology profile of misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Maternal death related to misoprostol overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Oral misoprostol and uterine rupture in the first trimester of pregnancy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Uterine rupture associated with the use of misoprostol in the gravid patient with a previous cesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Misoprostol for induction of labor with a live fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Infection after medical abortion: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Use of misoprostol during pregnancy and Möbius' syndrome in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

Epidemiological assessment of misoprostol teratogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2007.09.004

10.1016/J.IJGO.2007.09.004

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference